Premium
Thalidomide Therapy
Author(s) -
Naafs B.,
Faber W. R.
Publication year - 1985
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/j.1365-4362.1985.tb05400.x
Subject(s) - medicine , thalidomide , dermatology , peripheral neuropathy , drug , surgery , pharmacology , multiple myeloma , diabetes mellitus , endocrinology
In an open trial, 35 patients suffering from a variety of dermatologic conditions were treated with thalid‐omide. The drug was shown to be a valuable addition to the therapeutic armamentarium; however, the occurrence of a peripheral neuropathy will limit its use just as its teratogenic side effects have done for many years.